Webster Bank N. A. lifted its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 22.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 393 shares of the medical equipment provider’s stock after purchasing an additional 72 shares during the period. Webster Bank N. A.’s holdings in Intuitive Surgical were worth $205,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds have also added to or reduced their stakes in the company. Mirador Capital Partners LP boosted its stake in shares of Intuitive Surgical by 1.4% in the third quarter. Mirador Capital Partners LP now owns 3,526 shares of the medical equipment provider’s stock valued at $1,732,000 after buying an additional 50 shares during the period. M.E. Allison & CO. Inc. acquired a new stake in shares of Intuitive Surgical during the 4th quarter worth $449,000. Seilern Investment Management Ltd bought a new position in shares of Intuitive Surgical in the fourth quarter worth $82,517,000. Exome Asset Management LLC raised its stake in Intuitive Surgical by 16.8% in the third quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock valued at $3,649,000 after purchasing an additional 1,069 shares in the last quarter. Finally, Consolidated Planning Corp lifted its position in Intuitive Surgical by 17.4% during the third quarter. Consolidated Planning Corp now owns 8,099 shares of the medical equipment provider’s stock worth $3,979,000 after purchasing an additional 1,198 shares during the period. 83.64% of the stock is owned by institutional investors and hedge funds.
Analyst Ratings Changes
A number of analysts have recently weighed in on the stock. Evercore ISI upped their price target on shares of Intuitive Surgical from $490.00 to $530.00 in a report on Monday. Jefferies Financial Group lifted their price target on Intuitive Surgical from $475.00 to $575.00 in a research note on Monday. Robert W. Baird upped their price objective on Intuitive Surgical from $503.00 to $565.00 and gave the stock an “outperform” rating in a research report on Thursday, October 17th. Bernstein Bank lifted their target price on Intuitive Surgical from $655.00 to $700.00 and gave the company an “overweight” rating in a research report on Monday. Finally, BTIG Research increased their target price on shares of Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a report on Tuesday, November 26th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have given a buy rating to the stock. According to data from MarketBeat.com, Intuitive Surgical has a consensus rating of “Moderate Buy” and a consensus target price of $613.10.
Insider Transactions at Intuitive Surgical
In other news, CEO Gary S. Guthart sold 18,151 shares of the stock in a transaction dated Wednesday, October 30th. The shares were sold at an average price of $511.63, for a total value of $9,286,596.13. Following the completion of the sale, the chief executive officer now owns 24,219 shares in the company, valued at $12,391,166.97. This represents a 42.84 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CFO Jamie Samath sold 108 shares of the business’s stock in a transaction dated Tuesday, November 26th. The stock was sold at an average price of $542.06, for a total transaction of $58,542.48. Following the transaction, the chief financial officer now owns 8,757 shares in the company, valued at approximately $4,746,819.42. This trade represents a 1.22 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 42,265 shares of company stock valued at $21,964,281 over the last ninety days. 0.90% of the stock is currently owned by insiders.
Intuitive Surgical Price Performance
ISRG opened at $573.48 on Tuesday. Intuitive Surgical, Inc. has a fifty-two week low of $364.17 and a fifty-two week high of $616.00. The firm has a market capitalization of $204.26 billion, a PE ratio of 92.20, a P/E/G ratio of 5.19 and a beta of 1.39. The company’s 50-day moving average is $547.16 and its 200 day moving average is $505.21.
About Intuitive Surgical
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
See Also
- Five stocks we like better than Intuitive Surgical
- Roth IRA Calculator: Calculate Your Potential Returns
- Sizing Up a New Opportunity for NVIDIA Investors
- Buy P&G Now, Before It Sets A New All-Time High
- Is DeepSeek Challenging NVIDIA’s AI Dominance?
- Best Aerospace Stocks Investing
- The 3 Biggest M&A Stock Opportunities for 2025
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.